Results 21 to 30 of about 19,141 (206)

High-risk and low prevalence disease: Cardiac sarcoidosis and some of its mimics

International Journal of Cardiology: Heart & Vasculature, 2023
In this narrative review of cardiac sarcoidosis, based on a literature search using the terms “cardiac sarcoidosis”, “tuberculous myocarditis”, “Whipple’s disease and myocarditis”, and”idiopathic giant cell myocarditis”, I have defined cardiac ...
Oscar M.P. Jolobe
doaj   +1 more source

Challenges in diagnosing cardiac sarcoidosis: should we increase our index of suspicion?

Journal of Community Hospital Internal Medicine Perspectives, 2020
Sarcoidosis is a multisystem disease involving the lungs in up to 90% of cases; however, 30% of patients will have systemic sarcoidosis, including involvement of the heart. Cardiac sarcoidosis can affect any part of the heart and manifest in various ways,
Ariana Rose Tagliaferri
doaj   +1 more source

Adalimumab in the treatment of cardiac sarcoidosis: Single center case series and narrative literature review

Respiratory Medicine Case Reports, 2022
Background: Tumor necrosis factor (TNF) inhibitors have been used in the treatment of cardiac sarcoidosis, infliximab being the most commonly used.
Jaleel Jerry G. Sweis, Nabil William G. Sweis, Christian Ascoli, Benjamin Levin, Boaz Avitall, Israel Rubinstein, George Kondos, Daniel A. Culver, Marc Judson, Robert Baughman, Dawood Darbar, Wonder Drake, Shiva Shahrara, Leslie T. Cooper, Jr., Nadera J. Sweiss   +14 more
doaj   +1 more source

Case report: First-in-human combined low-dose whole-heart irradiation and high-dose stereotactic arrhythmia radioablation for immunosuppressive refractory cardiac sarcoidosis and ventricular tachycardia

Frontiers in Cardiovascular Medicine, 2023
BackgroundCardiac sarcoidosis is associated with heart failure, conduction abnormalities, and life-threatening arrhythmias including ventricular tachycardia (VT).
Martijn H. van der Ree, Martijn H. van der Ree, Martijn H. van der Ree, Claudia Herrera Siklody, Mathieu Le Bloa, Patrizio Pascale, Alessandra P. Porretta, Cheryl C. Teres, Jorge Solana Munoz, Adrian Luca, Giulia Domenichini, Mahmut Ozasahin, Raphael Jumeau, Pieter G. Postema, Pieter G. Postema, Camillo Ribi, Jean Bourhis, Luis Schiappacasse, Etienne Pruvot   +18 more
doaj   +1 more source

Cardiac sarcoidosis: diagnosis and management [PDF]

Reviews in Cardiovascular Medicine, 2020
Sarcoidosis is a chronic inflammatory disease of unknown etiology characterized by multi-organ involvement. End-organ disease consists of granulomatous inflammation, which if left untreated or not resolved spontaneously, leads to permanent fibrosis and ...
Eleftherios Markatis, Andreas Afthinos, Emmanouil Antonakis, Ilias C Papanikolaou
doaj   +1 more source

Cardiac magnetic resonance imaging-indeterminate/negative cardiac sarcoidosis revealed by 18F-fluorodeoxyglucose-positron emission tomography: two case reports and a review of the literature

Journal of Medical Case Reports, 2017
Background Sarcoidosis is an inflammatory disorder of immune dysregulation characterized by non-caseating granulomas that can affect any organ. Cardiac sarcoidosis is an under-recognized entity that has a heterogeneous presentation and may occur ...
S. C. Sasson, R. Russo, T. Chung, G. Chu, I. Hunyor, J. Williamson, A. Murad, A. Kane, S. Riminton, S. Limaye   +9 more
doaj   +1 more source

Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis

European Journal of Hybrid Imaging, 2021
Purpose To evaluate the diagnostic and prognostic significance of combined cardiac 18F-fluorodeoxyglucose (FDG) PET/MRI with T1/T2 mapping in the evaluation of suspected cardiac sarcoidosis.
Edward Cheung, Sarah Ahmad, Matthew Aitken, Rosanna Chan, Robert M. Iwanochko, Meyer Balter, Ur Metser, Patrick Veit-Haibach, Filio Billia, Yasbanoo Moayedi, Heather J. Ross, Kate Hanneman   +11 more
doaj   +1 more source

A rare cause of complete heart block in a middle-aged Indian woman

International Journal of Advanced Medical and Health Research, 2017
Sarcoidosis is a multisystem disease that might involve the heart during its course. Isolated cardiac involvement can occur in sarcoidosis without pulmonary and other systemic manifestations, and it could be the presenting manifestation.
Remyasri Nair, Purushotham Ramayya
doaj   +1 more source

Stable Extent of Recurrently Active Cardiac and Cutaneous Sarcoidosis

Frontiers in Medicine, 2021
Background: Recurrent or persistently active sarcoidosis is a risk factor for permanent organ damage. Whether this damage is due to accumulated focal injuries or progressive disease extent is not known, as the natural history of chronic inflammation in ...
Karen C. Patterson, Karen C. Patterson, Misha Rosenbach, Paco E. Bravo, Paco E. Bravo, Jacob G. Dubroff   +5 more
doaj   +1 more source

Myocardial Involvement in Patients With Histologically Diagnosed Cardiac Sarcoidosis: A Systematic Review and Meta‐Analysis of Gross Pathological Images From Autopsy or Cardiac Transplantation Cases

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2019
Background In patients with suspected cardiac sarcoidosis, late gadolinium enhancement on cardiovascular magnetic resonance imaging and/or 18F‐fluorodeoxyglucose uptake on positron emission tomography are often used to reach a clinical diagnosis of ...
Osama Okasha, Felipe Kazmirczak, Ko‐Hsuan Amy Chen, Afshin Farzaneh‐Far, Chetan Shenoy   +4 more
doaj   +1 more source